HONG KONG KANGJIA BIOLOGICAL LIMITED – Trademark Portfolio

Entity Type: 99

HONG KONG KANGJIA BIOLOGICAL LIMITED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include CAREDEAR and ENJOYOUTH. The owner is based in KWUN TONG.

FLAT E19, 10/F, NO.52 HUNG TO ROAD

KWUN TONG 999077 , HK

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ENJOYOUTH
ENJOYOUTH
Registered 2025
CAREDEAR
CAREDEAR
Registered 2024

Trademark Classifications

HONG KONG KANGJIA BIOLOGICAL LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does HONG KONG KANGJIA BIOLOGICAL LIMITED have?

HONG KONG KANGJIA BIOLOGICAL LIMITED has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does HONG KONG KANGJIA BIOLOGICAL LIMITED file in?

HONG KONG KANGJIA BIOLOGICAL LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are HONG KONG KANGJIA BIOLOGICAL LIMITED's most well-known trademarks?

HONG KONG KANGJIA BIOLOGICAL LIMITED's registered trademark portfolio includes well-known marks such as CAREDEAR and ENJOYOUTH. These are among 2 currently registered trademarks in the portfolio.

What is HONG KONG KANGJIA BIOLOGICAL LIMITED's trademark registration success rate?

HONG KONG KANGJIA BIOLOGICAL LIMITED has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.